Unit I Flashcards
Sedation
Analgesics AND sedative needed for patient and safety
Excessive sedation can cause…
Prolonged ventilation
Physical/psychological dependence
Increased length of hospital stay
Motor Activity Assessment Scale (MAAS)
0-6, 0 being unresponsive and 6 being dangerously agitated
6 would be great risk to themselves
Richmond Agitation-Sedation Scale (RASS)
Scale from -5 to +4
-5 is unresponsive, +4 is combative
Drugs for Short-Term Sedation
Benzodiazepines
Propofol
Dexmedetominde (Alpha-2 Receptor Agonist)
Ketamine
Drug for Intermediate Term Sedation
Lorazepam
Drug for Long Acting Sedation
Diazepam
Lorazepam
Ativan
Side effect: hypotension
Used for mechanically ventilated patients
Midazolam
Versed
Side effects: hypotension, respiratory depression, amnesia
Diazepam
Valium
Shorter acting; used for patients in alcohol withdrawal
Side effects: hypotension, respiratory depression
Antidote for Benzodiazepines
Romazicon, Flumazenil
Propofol Effects
Used for deep sedation
Rapid onset, rapid elimination
No amnesia effect
Use only on mechanically ventilated patients
Adverse Effects: elevated triglycerides, pancreatitis
Propofol Infusion Syndrome
Rare, usually in pediatrics over 48 hours
Cardiac arrest, metabolic acidosis, rhabdomyolysis
Propofol Characteristics
Lipid soluble solution (risk for infection)
IV use only
Change IV tubing every 12 hours
Rapid IV may precipitate hypotension
Dose range 5-80mcg/kg/min
Dexmedtomidine
Approved for short term use (< 24 hours)
Does NOT produce respiratory depression
Patients are arousable and alert when stimulated
Sympatholytic, sedative, analgesic, and opioid sparing properties
50% of patients not able to achieve therapeutic goal
Sedation Vacation (Spontaneous Awakening Trial)
- Discontinue sedation at the same time each day until patient wakes up (every shift)
- Assess patient’s level of alertness
- Resume sedation according to unit’s protocol
- Monitor patient closely to prevent harm from sedative withdrawal or agitation
Neuromuscular Blocking Agents (Paralytics)
Block transmission of nerve impulses by blocking cholinergic receptors
Muscle paralysis occurs
MUST have sedation and pain medication as well
Used in severe situations when sedatives are not enough to ensure ventilatory synchrony and patient safety
AMNESIA is desired outcome
Short Term NMB
Mivacurium (IVP)
Intermediate NMB
Vecuronium (IVP and infusion)
Long Acting NMB
Pancuronium (intermittent IV bolus)
Agitation
Psychomotor disturbance
Marked increase in both motor and psychological activities
Loss of control of action
Disorganization of thought
RASS scores +1 to -4
Use of restraints predictor
Delirium
Acute fluctuations in mental status
Rapid onset, reversible
Inattention
Cognitive changes
Perceptual differences
Hyperactive or hypoactive
Results in systemic illness, pain, sleep deprivation
Caused by infection, fever, metabolic fluctuations, electrolyte disturbances, medications
Risk Factors for Delirium “ICU Psychosis”
Prolonged ICU hospitalization
Sleep deprivation/disruption of circadian rhythm
Mechanically ventilated parents
Low arterial pH
Elevated serum creatinine
CURRENT USE OF BENZODIAZEPINES/OPIOIDS
Severity of illness
Delirium Manifestations
SUDDEN DECLINE FROM PREVIOUS MENTAL STATUS
Disorientation to time
Hallucinations
Auditory, tactile, or olfactory misperceptions
Hyperactive behaviors like agitation
Hypoactive behaviors like withdrawn/lethargic
CAM-ICU Assessment of Delirium
- Acute onset of mental status change
- Visual (picture) or Auditory (letter) Attention Screening Tool
- Altered LOC (RASS Score)
- Disorganized thinking (4 yes/no questions)
Treatment of Delirium
Nonpharmacologic first
Correct physiological problems (O2, pain, BUN, electrolytes, blood glucose, benzodiazepine adverse effects)
Pharmacological measures
Nonpharmacologic Management of Delirium
Noise reduction, light reduction, cluster cares, promote sleep, back massage, music, calm voice, visual cues to orientation
MINIMIZE SLEEP DEPRIVATION
EARLY MOBILIZATION
Pharmacologic Management of Delirium
Give Haloperidol
Neuroleptic Malignant Syndrome
Muscular rigidity, hyperthermia, sweating, fluctuations in VS
Critical crisis
Treatment for Neuroleptic Malignant Syndrome
- Dantrolene as muscle relaxant
- Management of fever
- Fluid volume replacement as needed
- Discontinue neuroleptic drug
- Bromocriptine for CNS toxication
Adverse Effects of Haloperidol
Orthostatic hypotension
Anticholinergic symptoms
Sedation
Prolonged QT interval, risk for dysrhythmias
ABCDE Bundle
A: Sedation Awakening Trial
B: Spontaneous Breathing Trial
C: Coordination
C: Choice of Analgesia and Sedation
D: Delirium Prevention and Management
E: Early Physical Mobility
Test Used Prior to ABGs
Allen’s Test
Compress radial and ulnar artery to blanch hand, release ulnar artery and make sure hand pinks up again
Draw from radial artery
Must be put on ice to prevent metabolism
In order for perfusion to happen…
Adequate O2 moving from lungs to body cells
Lungs must receive enough O2 to be perfused and ventilate
O2 must be transported via blood
Tissue demand for O2 determines how much O2 unloads from hemoglobin
PaO2
Partial pressure of oxygen in arterial blood
Dissolved and not bound to hemoglobin
80-100
SaO2
Arterial saturation of hemoglobin
Oxygen bound to hemoglobin
95-97%
PaCO2
Partial pressure of CO2 in arterial blood
CO2 dissolved in the blood
35-45
SpO2
Saturation of hemoglobin in peripheral capillaries
Noninvasive measurement
Estimate of SaO2
Greater than 93%
Oxyhemoglobin Curve–Right Shift
Caused by: Hypermetabolic states, decreased perfusion, decreased pH, acidosis, fever
Results in: decreased affinity of O2 for hemoglobin, increase in amount of O2 available for tissues
Oxyhemoglobin Curve–Left Shift
Caused by: decreased temperature, alkalosis, high pH
Results in: increased affinity of O2 for hemoglobin, but decreased amount of O2 released to tissues, less cellular activity
2,3-DPG
Phosphate that forms when red blood cells break down glucose to make ADT–measure of metabolism
Increased production by: thyroxine, HGH, epinephrine, testosterone, high altitudes
Decreased production by: aging
Carbonic Anhydrase Buffer System
H20 + CO2 (lungs) = H+ - HCO3 (kidneys)
Normal ABG Values
pH: 7.35-7.45
PCO2: 35-45
PO2: 80-100
HCO3: 22-26
Analysis of ABGs
Oxygenation Status: PaO2, SaO2, FiO2
Acid-Base Status: pH, pCO2, HCO3
ROME (Respiratory Opposite, Metabolic Equal)
Compensation
Body attempts to maintain homeostasis
When pH is WNL, but CO2 + HCO3 are not
Metabolic Alkalosis
Caused by steroid therapy, vomiting, GI suction, diuretic therapy, NA Bicarb intake
Loss of acid or gain of bicarb
Metabolic Acidosis
Gain of H+, increase in lactic acid, DKA, hypermetabolic state, intake acid (ASA), renal failure
Loss of HCO3, diarrhea
Respiratory Acidosis
Gain of CO2
Oversedation, hypoventilation, drug overdose, COPD, mechanical ventilation, head-spinal trauma, neuromuscular disease
Respiratory Alkalosis
Loss of CO2
Pregnancy, high altitude, PE, hypoxia, fever, increased metabolic state, anxiety/fear
Rationale for Mechanical Ventilation
Respiratory arrest
Procedure anesthesia/analgesia
Post-operative recovery
Poor ABGs
Deteriorating respiratory status
Airway protection
Types of Mechanical Ventilation
Negative Pressure Ventilation
Positive Pressure Ventilation
Negative Pressure Ventilation
Used for atelectasis
Air is pulled out of the lungs
Iron Lung
Positive Pressure Ventilation
Used for respiratory failure
Air is pushed into the lungs
High Frequency Jet Ventilation
Used for pediatrics and barotrauma patients
Neutrally Adjusted Ventilator Assistance
Used for pediatrics and barotrauma patients
Respiratory Volumes
Tidal volume
Inspiratory reserve volume
Expiratory reserve volume
Minute volume
Residual volume (dead space)
Sigh
Types of Breaths for Ventilated Patient
Controlled (by the ventilator; positive pressure)
Assisted (initiated by patient but delivered by the ventilator; positive pressure, little dips of negative pressure)
Spontaneous (regulated by the patient; negative pressure)
Normal Inspiration/Expiration Ratio
1 inspiration to 2 expiration
Exhalation 2x as long as inspiration
Tidal Volume
Volume of gas inhaled or exhaled
Minute Volume
Volume of gas entering or leaving the lungs per minute
Continuous Mandatory Ventilation (CMV)
All breaths controlled by the ventilator
Assisted Mandatory Ventilation
All breaths initiated by patient but delivered by the ventilator
Assist/Control Mandatory Ventilation (A/C)
Minimum number of controlled breaths plus any additional assisted breaths initiated by patient
Synchronized Mechanical Ventilation (SIMV)
Minimum number of controlled/assisted breaths
Additional spontaneous breaths by patient’s own effort and tidal volume
Insures that ventilated breaths occur at end-expiratory phase of respiratory cycle
No stacking of ventilated breaths on already inhaled chest volume
Facilitates ventilator tolerance
Continuous Positive Airway Pressure (CPAP)
All spontaneous breaths by patient
Slight elevation of airway pressures
NO MECHANICAL VENTILATION
MUST HAVE THE DRIVE TO BREATHE
Ventilator Settings
Mode: CMV, A/C, SIMV, CPAP
FiO2: % Oxygen
Respiratory Rate
Tidal Volume (volume per ventilated breath)
Positive End-Expiratory Pressure (PEEP)
Pressure Support Ventilation (PSV)
SIGHS and frequency
SENSITIVITY: 3-5 mm H2O negative pressure
Modes of Mechanical Ventilation for Servo 300
Pressure Controlled (PC)
Volume Controlled (VC)
Volume Support (VS)
Pressure Support (PS)
Pressure Regulated Volume Controlled (PRVC)
Pressure Controlled
Pressure cycled ventilations
Decelerating inspiratory flow
Pre-set rate and time
Volume Controlled
Similar to CMV
Volume cycled ventilations
Higher airway pressures than PC
Volume Support
Patient must trigger each breath
Spontaneous breaths with inspiratory pressure support until minimum tidal volumes and minute volumes are achieved
Tidal volumes adjusted if minute volumes below preset levels
Pressure Support
Patient must trigger each breath
Spontaneous breaths assisted with preset inspiratory pressures
Pressure Regulated Volume Controlled
Inspiratory pressures of ventilations are minimized to what is necessary for chest expansion
Insures tidal volume of ventilations
Preset rate; best for patients with ARDS
Minimizes inspiratory pressures and barotrauma
NAVA
A mode where the patient, specifically the brain, not us, decides when and how to breathe
Can be used invasively or non-invasively
Ultimate in synchronization–reduces barotrauma and overassist, and eases transition to nonventilated breathing
Better sleep quality, lung protective, less sedation needed
Who Can Use NAVA
Spontaneously breathing patients
Must have a working diaphragm
Patients greater than 500 grams
Ability to place either an NG or OG catheter
Who Can’t Use NAVA
Patients with an absent electrical signal from brain to diaphragm
Patients with paralysis/neuromuscular blockade
Esophageal bleeding
Inability to place an NG/OG tube
Actively used cardiac pacemaker
Noninvasive Positive Pressure Ventilation
Alternative to invasive MV
Indicated for respiratory distress with respiratory drive
Rationale: reduces workload of breathing, decreased number of ventilator days, decreased ICU days, decreased length of stay in hospital
Ideal Patients for Noninvasive Positive Pressure Ventilation
Nocturnal hypoventilation (sleep apnea)
Chronic hypoventilation (neuromuscular disease, COPD)
Acute hypoventilation
Acute cardiogenic pulmonary edema
Conscious and cooperative
Able to protect airway
Contraindications to Noninvasive Positive Pressure Ventilation
Respiratory arrest
Cardiovascular shock
Risk for aspiration
Severe hypoxemia, acidemia
Uncooperative patient (agitation)
Facial, esophageal, or gastric surgery
Cranial trauma or burns
Initiation of NPPV–Settings
Interface (mask & face)
Machine
Mode
Trigger, cycle, rise time
IPAP (inspiratory pressure)
EPAP (PEEP)
FiO2
Steps for Initiation of NPPV
- Explain process, select mask/ventilator
- Fit mask
- Initiate NPPV while holding mask in place
- Titrate inspiratory pressure to patient comfort and titrate upward
- Secure mask
- Monitor O2 saturation, titrate FiO2 for O2 sat > 90%
- Titrate EPAP to minimize trigger effort and increase O2 sat
- Check for air leaks
- Avoid peak airway pressures > 20 cm H2O
- Continue to coach patient
NPPV Nursing Care
Skin breakdown
Gastric insufflation with IPAP > 20 cm H2O
Air leaks
Conjunctival irritation
Nasal or oral dryness
Claustrophobia
Outcome for Dysfunctional Ventilatory Weaning Response
Wean from ventilator with IER ABGs
Remain free from unresolved dyspnea
Effectively clear airway
Interventions for Dysfunctional Ventilatory Weaning Response
Exercise respiratory muscles
Reduce oxygen consumption
Maintain adequate oxygenation
Pressure support ventilation as needed
Maintain adequate rest and nutrition prior to weaning
Readiness to be Weaned from Mechanical Ventilation
PEEP < 5
FiO2 < 40-50%
pH > 7.25
PaO2/FiO2 ratio > 200
Negative inspiratory force of -20 cm H2O or more
Hemodynamic stability
Patient is adequately nourished, rested, not sedated
PaO2/FiO2 Ratio
- Obtain PaO2 value (mmHg)
- Convert FiO2 to decimal (e.g. 32% –> 0.32)
- Divide PaO2 by FiO2 (e.g. 92 mmHg / 0.32 == 287.5)
- Criterion for weaning if ratio > 200
- Normal is about 300
Expected PaO2/FiO2 Ratio
FiO2 x 5 == estimate of expected value if lungs were functioning normally
The larger the distance from the expected value, the worse the lung function
Ventilator Nursing Diagnoses
Impaired spontaneous ventilation
Ineffective airway clearance
Ineffective breathing pattern
Impaired verbal communication
Impaired gas exchange
Fear
Powerlessness
Social isolation
Risk for infection
Communication with Patients on Ventilator
Patients are not hard of hearing
Patients usually are not unconscious
Verbal communication: written on paper, signs
Nonverbal communication: nodding yes/no to questions, gestures with hands
Complications of Mechanical Ventilation
Pulmonary: barotrauma, damage to nasal/oral mucosa, oxygen toxicity
Acid/base imbalances
Aspiration
Ventilation associated pneumonia
Ventilator dependence
Cardiovascular: decreased CO
GI: stress ulcers
Endocrine: fluid retention = ADH
Psychosocial: loss of control, anxiety
Ventilator Alarms
Disconnect; check patient, check connections from patient to ventilator, Ambu bag at bedside, use if malfunction of ventilator
Low-pressure alarm: leaks, decreased compliance
High-pressure alarm: pressure exceeds selected threshold
Causes: secretions, tubing condensation, biting ET tube, increased resistance (bronchospasms), decreased compliance (pulmonary edema)
Ventilator Induced Lung Injury
VILI is due to volume, overdistention of lung
Ventilator Associated Pneumonia
Artificial airway associated pneumonia (AAAP)
Risk of VAP among intubated patients: 8-25%
Consequences: increased length of stay, increased cost, mortality up to 27%
Never Event: hospital eats cost of treatment
Interventions to Decrease Risk of VAP
Proper handwashing
HOB > 30 degrees
Frequent/careful oral hygiene
Proper ET cuff inflation
Stress ulcer prophylaxis
Increase use of NPPV
Insure assessments of daily spontaneous breathing trials
Oral tracheal instead of nasotracheal intubation
Decrease frequency of ventilator circuit tubing changes
Definition of ARDS
Within one week of injury or new or worsening respiratory symptoms
Imaging with bilateral opacities (not fully explained by nodules, effusions)
Edema not explained by cardiac issues
Mild/moderate/severe p/f ratio abnormalities
Pathophysiology of Acute Lung Injury
Systemic Inflammatory Response Syndrome
Release of mediators such as histamine, leukotrienes, TNF-a –>
Increased alveolar-capillary permeability –>
Diffuse pulmonary edema, impaired gas exchange –>
Destruction of surfactant –>
Decreased compliance, increased resistance –>
Direct Risk Factors for ALI
Pulmonary infections
Toxic inhalation
Aspiration
Pneumonia
Indirect Risk Factors for ALI
Shock, sepsis
Hypothermia, hyperthermia
Drug overdose
DIC
Multiple transfusions
Burns
Eclampsia
Trauma
Severe Sepsis
- Known or suspected infection
- Two signs of SIRS
- At least 1 organ failing or dysfunctional
SIRS
- Core temperature > 100.4
- HR > 90
- RR > 20 or paCO2 < 32mmHg
- WBC > 12,000 or < 4,000, or > 10% immature neutrophils/bands
Transfusion-Related ALI (TRALI)
Most common cause of transfusion-associated mortality
Potentially preventable
Improved antigen screening
Ventilator-Induced Lung Injury (VILI)
Ventilator pressures
Lung strain
Inflammation
LIPS
Lung Injury Prediction Score
LIPS Risk Factors
High risk trauma
High risk surgery
Aspiration
Sepsis, shock
Pneumonia
Pancreatitis
LIPS Risk Modifiers
Alcohol abuse
Hypoalbuminemia
Tachypnea
O2 supplementation
Chemotherapy
Obesity, diabetes
Checklist for Lung Injury Prevention (CLIP)
Respiratory support
Aspiration precautions
Infection control
Fluid management
Transfusion
Structured handoff
Physiology of ALI
Exudative Phase
Fibroproliferative Phase
Resolution Phase
Exudative Phase of ALI
First 72 hours
Increased capillary permeability (leakage of fluids into interstitial tissues, compression of terminal bronchioles)
Fibroproliferative Phase of ALI
Gas exchange compromised
Hypoxemia from atelectasis, decreased diffusion
Resolution Phase of ALI
Recovery over several weeks
Reestablish a/c membrane
Goals of Therapy for ALI
Recruitment (opening) of collapsed alveoli
Prevent barotrauma by tolerating “permissive hypercarbia” (slight respiratory acidosis)
Oxygenation: ratio of paO2/FiO2 > 200 (ratio of paO2/FiO2 = 300 is normal)
Investigational Interventions for ALI
Synthetic surfactant instilled via ET tube
Extra-corporeal gas exchange (ECMO)
Inhaled liquid nitric oxide with HFJV
Oxygenation (SpO2)
O2 for metabolism
Measures percentage of oxygen in RBCs
Changes within 5 minutes
Ventilation (Capnography)
CO2 from metabolism
EtCO2 measures exhaled CO2 at point of exit
Changes within 10 seconds
Capnography
Available for spontaneously breathing and for intubated patients
Capnography Waveforms
The higher the waveform, the more CO2
Normal EtCO2 is 35-45
Length of waveform corresponds to respiratory rate
Shark Fin in Capnography
Possible causes include partially kinked airway, presence of foreign body, obstruction of expiratory limb of vent circuit, BRONCHOSPASM
Curare Cleft in Capnography
Appears when NMBAs begin to wear off
Depth of cleft inversely proportional to degree of blockade
EtCO2 > 45
Hypoventilation
Respiratory acidosis
Fever
Bronchospasms
EtCO2 < 35
Hyperventilation
Respiratory alkalosis
Partial airway obstruction
PE
Cardiac arrest
Hypotension, hypothermia, hypovolemia
Acute Kidney Injury
An abrupt reduction in kidney function, leading to retention of nitrogenous and other waste products normally eliminated by the kidneys
High incidence in the aging population with greater susceptibility and illness severity, comorbidities
Acute Kidney Injury Statistics
1% of acute hospital admissions
Complicates 7% of inpatient episodes
Increases mortality rate to 38-80%
Pre-renal Acute Kidney Injury
Hypo-perfusion of the kidneys
Caused by shock states (hypovolemia, cardiogenic, distributive), sepsis, occlusion of renal arteries, altered auto-regulatory capability
Intra-renal Acute Kidney Injury
Damage to renal parenchyma
Caused by nephrotoxic antibiotics (aminoglycosides), heavy metal poisoning, hemolysis, organic solvents, fungicides/pesticides, radiopaque contrast agents, NSAIDS
Post-renal Acute Kidney Injury
Reflux of urine flow due to obstruction beyond the kidneys
Caused by kidney stones, UTIs, BPH, anticholinergics, tumors, blood clots
Urinalysis for Prerenal AKI
Na: < 5 mEq/L
SpecGrav: > 1.020
BUN:CR: > 20:1
Urine is concentrated, kidneys are hanging on to water
Urinalysis for Intrarenal AKI
Na: 10-40 mEq/L
SpecGrav: 1.010
BUN:Cr: 10:1
Urine is dilute, kidneys are damaged and unable to concentrate urine, water is spilling out
RIFLE Criteria
Severities: RISK, INJURY, FAILURE
Outcomes: LOSS of renal function, ESKD
RIFLE-Risk
Rise in SCr level of at least 0.3
0r increased 1.5x normal
Urine output reduction to 0.5 for more than 6 hours
RIFLE-Injury
SCr increased 2x normal
Urine output reduction to 0.5 for more than 12 hours
RIFLE-Failure
SCr increased 3x normal
0r > 4 or acute rise > 0.5
UO < 0.3 for 24 hours or anuria for 12 hours